Standard Dental Labs Signs $10 Million Equity Purchase Agreement with Twenty Four Capital
Facility gives the Company discretion to access equity capital over time to support its Florida dental laboratory strategy
October 19, 2026 09:24 ET | Source: Standard Dental Labs Inc.
ORLANDO, Fla., Oct. 19, 2026 -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”), after several weeks of negotiation, today announced that it finalized its common stock purchase agreement with Twenty Four Capital LLC over the weekend. The agreement provides for the potential sale of up to $10 million of SDL common stock, subject to its terms and conditions.
The facility is designed to give SDL discretion over when to request purchases and how much capital to seek, within the agreement’s limits. Twenty Four Capital is obligated to purchase shares under a qualifying purchase notice, subject to the applicable conditions. SDL is not required to sell any shares. The $10 million figure represents the maximum aggregate gross purchase price contemplated by the agreement; it does not represent funding received at signing or a guarantee that SDL will receive the full amount.
Purchase prices are determined using market-based pricing formulas specified in the agreement. The amount SDL can obtain in any purchase will depend in part on the market price and trading volume of its shares, as well as satisfaction of the agreement’s other conditions. Any shares sold under the facility would dilute existing stockholders.
“Finalizing this agreement is an important step in expanding our financing options as we develop our Florida laboratory network,” said James D. Brooks, President and Chief Executive Officer of Standard Dental Labs Inc. “The facility allows us to decide when to seek funding in light of our operating needs and market conditions. We expect to evaluate its use alongside our other financing options as we pursue laboratory acquisitions and invest in our operations.”
SDL expects to use any proceeds it receives under the agreement for working capital, investments in its laboratory operations, potential acquisitions and general corporate purposes. The Company’s ability to complete acquisitions remains subject to due diligence, definitive agreements, financing and applicable closing conditions.
About Twenty Four Capital LLC
Twenty Four Capital LLC is a principal capital provider that develops structured equity and liquidity solutions for public companies and significant shareholders. Its offerings include structured equity facilities and customized financing solutions.
About Standard Dental Labs Inc.
Standard Dental Labs Inc. is a Florida-focused dental laboratory company pursuing growth through acquisitions and investment in domestic production capabilities. SDL serves dental practices through its laboratory operations and is focused on digital workflows, quality and responsive service. Its common stock trades on the OTCQB under the symbol TUTH.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the availability and potential use of the equity purchase facility, future financing, laboratory investments, acquisitions and growth plans. Words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “may” and similar expressions may identify these statements.
Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties. Actual results may differ materially. Among other factors, the Company may be unable to satisfy the conditions for purchases under the agreement; market price, trading volume and other contractual limits may restrict the amount or timing of funding; and the issuance of shares may dilute existing stockholders. Additional risks include financing availability, acquisition and integration risks, customer retention, operating performance and the risks described in the Company’s filings with the Securities and Exchange Commission and disclosures published through OTC Markets.
The $10 million maximum under the agreement should not be interpreted as cash currently available to the Company or as an assurance that the Company will receive that amount. Readers should not place undue reliance on forward-looking statements, which speak only as of the date made. Standard Dental Labs Inc. undertakes no obligation to update them except as required by law.
Investor & Media Contact
Standard Dental Labs Inc.
424 E Central Blvd, Suite 308, Orlando, FL 32801
Phone: (407) 789-1923
Email: [email protected]
Investors: https://sdl.care/investors
SOURCE: Standard Dental Labs Inc.